Title: Phibro Animal Health Corp (PAHC) 10K Annual Reports & 10Q SEC Filings
URL: https://last10k.com/sec-filings/pahc

HOME


LOGIN


PREMIUM


FREE TRIAL


SEC FILINGS


STOCK SCREENERS


EARNINGS


TRENDING


STOCKTWITS


INSIDER TRADING


SENTIMENT ANALYSIS


MANAGER PORTFOLIOS


LATE CORPORATE NEWS






				 



Phibro Animal Health Corp (PAHC) SEC Filing 10-K Annual Report for the fiscal year ending Sunday, June 30, 2024


Home
SEC Filings
Phibro Animal Health Corp (PAHC)
10-K Annual Report Wed Aug 28 2024






SEC Filings



 
PAHC Valuations





Intrinsic Value





Financial Stability





Financial Ratios





Insider Trades





Manager Portfolios





Notifications





 
PAHC Annual Reports
				  





10-K Annual Report August 2024


PDF

PDF


Select PDF Feature:
Include Exhibits
Highlight YoY Changes
Highlight Sentiment

10-K Only


Word
Excel
CSV


Table of Contents
and Risk Factors Summary
Market Ranking and Other Industry Data
Trademarks, Service Marks and Trade Names
Business
Risk Factors
Unresolved Staff Comments
Cybersecurity
Properties
Legal Proceedings
Mine Safety Disclosures
Market for Registrants Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities

Managements Discussion and Analysis of Financial Condition and Results of Operations
Quantitative and Qualitative Disclosures About Market Risk
Financial Statements and Supplementary Data
Changes in and Disagreements with Accountants on Accounting and Financial Disclosure
Controls and Procedures
Other Information
Disclosure Regarding Foreign Jurisdictions that Prevent Inspections
Directors, Executive Officers and Corporate Governance
Executive Compensation
Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters
Certain Relationships and Related Transactions, and Director Independence
Principal Accountant Fees and Services
Exhibits and Financial Statement Schedules
Form 10K Summary
SIGNATURES








									10-K Annual Report August 2023																






									10-K Annual Report August 2022																






									10-K Annual Report August 2021																






									10-K Annual Report August 2020																






									10-K Annual Report August 2019																






									10-K Annual Report August 2018																






									10-K Annual Report August 2017																






									10-K Annual Report August 2016																






PAHC Quarterly Reports
				  





									10-Q Quarterly Report May 2024																






									10-Q Quarterly Report February 2024																






									10-Q Quarterly Report November 2023																






									10-Q Quarterly Report May 2023																






									10-Q Quarterly Report February 2023																






									10-Q Quarterly Report November 2022																






									10-Q Quarterly Report May 2022																






									10-Q Quarterly Report February 2022																






									10-Q Quarterly Report November 2021																






									10-Q Quarterly Report May 2021																






PAHC Corporate News
				  





									Earnings ReleaseFinancial Exhibit																	August 2024







									Financial ExhibitOther Events																	July 2024







									Financial ExhibitNew AgreementNew Financial Obligation																	July 2024







									Earnings ReleaseFinancial Exhibit																	May 2024







									Financial ExhibitOther Events																	May 2024







									Financial ExhibitNew AgreementRegulated Disclosure																	April 2024







									Earnings ReleaseFinancial Exhibit																	February 2024







									Financial ExhibitOther Events																	February 2024







									Event for OfficersFinancial ExhibitRegulated Disclosure																	February 2024







									Earnings ReleaseFinancial Exhibit																	November 2023













Last10K.com | 10-K Annual Report Wed Aug 28 2024






Phibro Animal Health Corp


													CIK: 1069899
																										Ticker: PAHC




Earnings Press Release
 10-K Annual Report
 10-K YoY Changes
 Annual Proxy




Phibro Animal Health Corp

HISTORY
TOOLS


CIK: 1069899
Ticker: PAHC




​Exhibit 99.1​​​​For Immediate Release​Phibro Animal Health Corporation Reports Third Quarter Results, Updates Financial Guidance​TEANECK, N.J., May 8, 2024 (Business Wire) – Phibro Animal Health Corporation (Nasdaq: PAHC) (“Phibro” or the “Company”) today announced financial results for its third quarter ended March 31, 2024 and its updated financial guidance for the year ending June 30, 2024. ​Highlights for the three months ended March 31, 2024 (compared to the three months ended March 31, 2023)​-Net sales of $263.2 million, an increase of $17.6 million, or 7%-Net income of $8.4 million, a decrease of $1.6 million-Diluted earnings per share of $0.21, a decrease of $0.04-Adjusted EBITDA of $29.7 million, an increase of $2.3 million, or 9%-Adjusted net income of $12.7 million, an increase of $1.1 million, or 9%-Adjusted diluted EPS of $0.31, an increase of $0.02, or 9%​We affirm our previously issued fiscal year 2024 guidance for the following measures:​–Net sales of $980 million to $1.020 billion–Adjusted EBITDA of $106 million to $112 million–Adjusted net income of $42 million to $47 million–Adjusted diluted EPS of $1.04 to $1.16–   Adjusted effective tax rate of 28% to 30%​We have updated our fiscal year 2024 guidance for the following measures:​-Net income of $7 million to $12 million-Diluted EPS of $0.17 to $0.30​Our guidance is on a standalone basis without giving effect to the acquisition of Zoetis’ Medicated Feed Additive portfolio.​COMMENTARY​“I am extraordinarily proud of our third quarter performance. Our Animal Health segment delivered double digit top line growth, led by 26% growth in our vaccine business and an exceptional 16% growth in our MFAs and other business. This translated to an overall growth of 9% in Adjusted EBITDA,” said Jack Bendheim, Phibro’s Chairman, President, and Chief Executive Officer.​Jack continued, “This growth was achieved while at the same time our team was heavily involved in the process that led to our announcement last week of our signed agreement to purchase Zoetis’ Medicated Feed Additive portfolio and certain water soluble products. We are excited to bring the people and products included in the transaction to Phibro and we are very confident that we have the operational strength and focus to not only have a smooth transition but to maximize the opportunity related to this portfolio of 1The following information was filed by Phibro Animal Health Corp (PAHC) on Wednesday, May 8, 2024 as an 8K 2.02 statement, which is an earnings press release pertaining to results of operations and financial condition. It may be helpful to assess the quality of management by comparing the information in the press release to the information in the accompanying 10-K Annual Report statement of earnings and operation as management may choose to highlight particular information in the press release. 

Please wait while we load the requested 10-K report or click the link below:https://last10k.com/sec-filings/report/1069899/000155837024012517/pahc-20240630x10k.htm


View differences made from one year to another to evaluate Phibro Animal Health Corp's financial trajectory





Sample 10-K Year-over-Year (YoY) Comparison



Compare this 10-K Annual Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Phibro Animal Health Corp.

Continue







Assess how Phibro Animal Health Corp's management team is paid from their Annual Proxy





Screenshot example of actual Proxy Statement




Phibro Animal Health Corp's Definitive Proxy Statement (Form DEF 14A) filed after their 2024 10-K Annual Report includes:

Voting Procedures
Board Members
Executive Team
Salaries, Bonuses, Perks
Peers / Competitors


Continue














SEC Filing Tools




 Sentiment
 Sections
 Exhibits
 Stats


 



 Rating					
Learn More










Filter Sentiment:



All






Positive




Negative





Filter Category:




All





Financial







Legal






Revenue






M & A






Other






Filter Subcategory:




All






Cash Flow






Geography






Income





Earnings







Debt






Expense






Product






Dividend






Shares






Other







 Inside Phibro Animal Health Corp's 10-K Annual Report:


 Financial - Cash Flow   Highlight
However, we could incur judgments, enter into settlements or revise our expectations regarding the outcome of certain matters, and such developments could have a material adverse effect on our results of operations or cash flows in the period in which the amounts are paid and/or accrued.



 Other - Other   Highlight
Certain of these contingencies could result in losses, including damages, fines and/or civil penalties, and/or criminal charges, which could be substantial.

 Other - Other   Highlight
Potential physical risks from climate change may include altered distribution and intensity of rainfall, prolonged droughts or flooding, increased frequency of wildfires and other natural disasters, rising sea levels and a rising heat index, any of which could cause negative impacts to our and our customers’ businesses.

 Other - Other   Highlight
We cannot know if the conflict could escalate and result in broader economic and security concerns that could adversely affect our business, financial condition, or results of operations.

 Other - Other   Highlight
In addition to competition from established participants, there could be new entrants to the animal health medicines and vaccines industry in the future.

 Other - Other
Unanticipated market or macroeconomic events...Read more

 Other - Other
Adverse weather events and natural...Read more

 Other - Other
Actual results that differ from...Read more

 Other - Other
In addition, campaigns by interest...Read more

 Legal - Other
Finalizing audits with the relevant...Read more

 Other - Other
Our operations, and the activities...Read more

 Revenue - Geography
Foreign currency losses, net for...Read more

 Other - Other
Climate driven changes could have...Read more

 Other - Other
Climate change may negatively impact...Read more

 Financial - Income
Because there are a number...Read more

 Other - Other
Our assessments concerning uncertain tax...Read more

 Other - Other
The physical changes caused by...Read more

 Other - Other
The potential impact of the...Read more

 Other - Other
Critical accounting policies are those...Read more

 Financial - Income
We evaluate our tax positions...Read more

 Other - Other
Other risks to our meeting...Read more

 Other - Other
The prolonged continuation or escalation...Read more

 Financial - Earnings
Performance Products gross profit decreased...Read more

 Revenue - Geography
We consider foreign currency gains...Read more

 Financial - Debt
Additionally, the terms of our...Read more

 Legal - Other
We have developed programs to...Read more

 Other - Other
Those adverse consumer views related...Read more

 Financial - Expense
Such regulations could result in...Read more

 Financial - Income
We establish valuation allowances for...Read more

 Financial - Expense
Changes in interest expense, net...Read more

 Legal - Other
Tax law requires certain items...Read more

 Revenue - Product
If such events affect our...Read more

 Other - Other
In April 2016, the FDA...Read more

 Revenue - Product
Net sales of nutritional specialty...Read more

 Legal - Other
While we believe that our...Read more

 Financial - Earnings
Net cash provided by operating...Read more

 Financial - Earnings
Adjusted net income and adjusted...Read more

 Other - Other
We believe global population growth,...Read more

 Financial - Cash Flow
Such circumstances may include a...Read more

 Other - Other
At June 30, 2024, we had $176.0...Read more

 Financial - Income
The effective income tax rate...Read more

 Financial - Expense
Inventory decreased by $11.7 million...Read more

 Financial - Earnings
Adjusted diluted earnings per share...Read more

 Financial - Income
Inherent in determining our annual...Read more

 Financial - Expense
For the year ended June 30, 2024,...Read more

 Financial - Earnings
Cash provided by net income,...Read more

 M & A - Other
Our future debt levels and...Read more

 Revenue - Product
Proceeds from insurance premium financing,...Read more

 Legal - Other
As such, the nature of...Read more

 Other - Other
We had outstanding letters of...Read more

 Financial - Expense
As such, we are exposed...Read more

 Revenue - Product
Accounts receivable used $8.7 million...Read more

 Other - Other
Net payments on our revolving...Read more

 Financial - Earnings
Adjusted net income and adjusted...Read more

 Other - Other
Capital expenditures were $41.2 million,...Read more

 Other - Other
Capital expenditures were $51.8 million,...Read more

 Other - Other
Cash provided in the ordinary...Read more

 Other - Other
Under certain circumstances, we might...Read more

 Financial - Income
Our effective income tax rate...Read more

 Other - Other
In order to provide immediate...Read more

 Financial - Income
The effective income tax rate...Read more

 Legal - Other
We regularly re-evaluate our tax...Read more

 Financial - Income
The effective income tax rate...Read more

 Revenue - Product
This enables us to monitor...Read more

 Legal - Other
If the indemnified party were...Read more

 Revenue - Product
Our estimates for variable consideration...Read more

 Other - Other
Accounts payable provided $12.0 million...Read more

 Financial - Dividend
We currently intend to pay...Read more

 Revenue - Product
Cash provided by accounts receivable...Read more

 Legal - Other
We devote considerable resources to...Read more

 Financial - Expense
Corporate expenses increased $8.3 million...Read more

 Financial - Expense
Corporate expenses increased $8.3 million...Read more

 Other - Other
November 2023, the FDA issued...Read more

 Financial - Cash Flow
We believe our cash on...Read more

 Other - Other
At June 30, 2024, our cash and...Read more

 Revenue - Product
Animal Health and Mineral Nutrition...Read more

 M & A - Other
Goodwill represents the excess of...Read more

 Financial - Cash Flow
Based upon our experience to...Read more

 Revenue - Product
Variable consideration includes customer programs...Read more

 Other - Other
We commit substantial effort, funds...Read more

 Revenue - Product
Revenue reflects the total consideration...Read more

 Financial - Income
We record the GILTI-related aspects...Read more

 Other - Other
Hamas terrorists invaded Israel, first...Read more

 Financial - Dividend
Our future ability to pay...Read more

 M & A - Other
Borrowings under the Delayed Draw...Read more

 Revenue - Product
Net sales of MFAs and...Read more

 Other - Other
We conduct operations in many...Read more

 Other - Other
We believe we will be...Read more

 Financial - Expense
SG&A for the year ended...Read more

 Other - Other
The FDA also provided notice...Read more

 Legal - Other
The nature of our current...Read more

 Other - Other
We measure our overall performance...Read more

 M & A - Other
Our future success also depends...Read more

 Financial - Income
Our effective income tax rate...Read more

 Financial - Shares
Our Board of Directors has...Read more

 Financial - Earnings
We expect to repatriate approximately...Read more

 Financial - Earnings
We expect to repatriate approximately...Read more

 Revenue - Product
Net sales of vaccines increased...Read more

 Other - Other
In July 2024, we entered...Read more

 Legal - Other
We have requested a full...Read more

 M & A - Other
Also included in the Proposed...Read more

 Legal - Other
The majority of our R&D...Read more

 Other - Other
In addition, we periodically reassess...Read more

 Financial - Income
Our future effective income tax...Read more

 Other - Other
Any reputational harm to the...Read more

 Other - Other
We do not believe that...Read more

 Other - Other
We can provide no assurance...Read more

 Other - Other
Our competitors include stand-alone animal...Read more

 Revenue - Product
Sales returns and product recalls...Read more

 Other - Other
We typically utilize third-party valuation...Read more

 Financial - Earnings
We report adjusted net income...Read more

 Other - Other
We develop, manufacture and market...Read more

 M & A - Other
We anticipate that the Proposed...Read more

 Financial - Expense
Potential costs and expenses may...Read more

 Other - Other
Our contractual obligations include maturities...Read more

 M & A - Other
In April 2024, we entered...Read more

 Other - Other
In particular, there is increased...Read more

 Other - Other
A significant escalation of the...Read more

 Other - Other
Additionally, at various sites, our...Read more

 Other - Other
There are no restrictions on...Read more

 Financial - Expense
We consider business restructuring costs...Read more

 Other - Other
In response to the armed...Read more

 Financial - Dividend
We paid $19.4 million in...Read more

 Financial - Dividend
We paid $19.4 million in...Read more

 Other - Other
Unusual, in this context, may...Read more

 Financial - Income
The provision for income taxes...Read more

 Other - Other
Our assessment is based on...Read more

 Other - Other
We regularly monitor our accounts...Read more

 Other - Other
There can be no assurance...Read more

 Other - Other
Our future success depends on...Read more

 M & A - Other
Completion of the Proposed Acquisition...Read more

 Other - Other
We market approximately 750 product...Read more

 Other - Other
Principal methods of competition vary...Read more

 Financial - Expense
We manufacture some of our...Read more

 Other - Other
Our products help prevent, control...Read more

 Other - Other
We currently do not use...Read more

 Other - Other
The amount of the impairment...Read more

 Other - Other
The fair values are based...Read more

 Other - Other
Significant judgment may be required...Read more

 Other - Other
In July 2020, the FDA...Read more

 Other - Other
Management’s Discussion and Analysis of...Read more

 Financial - Income
The provision for income taxes...Read more

 Legal - Other
In January 2024, Phibro filed...Read more

 Other - Other
We may elect to assess...Read more

 Financial - Income
Deferred tax assets generally represent...Read more

 Other - Other
Our estimates of the useful...Read more

 Other - Other
The potential impacts of any...Read more

 M & A - Other
Assets acquired and liabilities assumed...Read more

 Other - Other
On October 7, 2023, Hamas...Read more

 Revenue - Product
For the year ended June 30, 2024,...Read more

 Other - Other
Our limited intent for the...Read more

 Financial - Income
Deferred tax liabilities generally represent...Read more

 Other - Other
Historically, we have not had...Read more

 Financial - Expense
Accrued expenses and other liabilities...Read more

 Financial - Income
The provision for income taxes...Read more

 Financial - Expense
Mineral Nutrition SG&A increased $0.4...Read more

 Other - Other
We are developing microbial products...Read more

 Other - Other
Certain of our businesses have...Read more

 Financial - Expense
We are subject to currency...Read more

 Financial - Expense
In addition, we incur selling...Read more

 Revenue - Product
Should we be unable to...Read more

 Financial - Earnings
Gross margin increased 30 basis...Read more

 Other - Other
We have considered the current...Read more

 Financial - Debt
Proceeds from the 2023 Incremental...Read more

 Other - Other
There has been a broad...Read more

 Other - Other
While the situation surrounding the...Read more

 Other - Other
Since the conflict began, the...Read more

 Other - Other
Not all accounting policies require...Read more

 Other - Other
We believe many of our...Read more

 Other - Other
The recognition and measurement of...Read more

 Financial - Expense
Animal Health SG&A increased $10.5...Read more

 Other - Other
The continuation or escalation of...Read more

 Other - Other
Financing activities provided $27.0 million...Read more

 Financial - Cash Flow
We recognize an impairment loss...Read more

 Other - Other
The classification of our products...Read more

 Other - Other
A manufacturing plant in Neot...Read more

 Other - Other
Other current assets provided $11.0...Read more

 Financial - Earnings
We intend to continue to...Read more

 Financial - Income
Our annual effective income tax...Read more

 Other - Other
Consequently, we are unable to...Read more

 Other - Other
We have no production or...Read more

 Other - Other
Operating activities provided $13.3 million...Read more

 Other - Other
Operating activities provided $87.6 million...Read more

 M & A - Other
The product portfolio to be...Read more

 Other - Other
As of the date of...Read more

 Financial - Expense
Climate change regulations continue to...Read more

 Financial - Earnings
We report adjusted net income...Read more

 Other - Other
Livestock producers may experience decreased...Read more

 Other - Other
We review these tax uncertainties...Read more

 Financial - Cash Flow
Significant estimates and assumptions inherent...Read more

 Financial - Expense
Known costs and expenses under...Read more

 Financial - Expense
Initial borrowings were used to...Read more

 Legal - Other
In many instances, the ultimate...Read more

 Financial - Expense
Some of these differences are...Read more

 Other - Other
Because we have transactions denominated...Read more

 Revenue - Product
We record reductions to revenue...Read more

 Other - Other
Such estimates are based on...Read more

 Other - Other
Our products that contain virginiamycin,...Read more

 Other - Other
We periodically review our long-lived...Read more

 Revenue - Product
Although a portion of our...Read more

 Revenue - Product
Although a portion of our...Read more

 Other - Other
Our companion animal development pipeline...Read more

 Other - Other
Significant judgment also may be...Read more

 Revenue - Product
We calculate DSO based on...Read more

 Other - Other
In addition to animal health...Read more

 Other - Other
This second action is based...Read more

 Revenue - Product
We recognize revenue from product...Read more

 Other - Other
Some in the public perceive...Read more

 Revenue - Geography
Current period losses were driven...Read more

 Other - Other
In the event of adverse...Read more

 Financial - Expense
Cash used for inventory was...Read more

 Other - Other
Substantially all of these contingencies...Read more

 Revenue - Product
Changes in net sales from...Read more

 Revenue - Product
We continue to invest in...Read more

 Financial - Income
Operating income decreased $18.5 million...Read more

 Other - Other
We calculate the ratio of...Read more

 Other - Other
We assess goodwill for impairment...Read more

 Financial - Expense
Inventory provided $2.6 million of...Read more

 Legal - Other
We are subject to numerous...Read more

 Financial - Expense
Accrued expenses and other liabilities...Read more

 Other - Other
Such evaluation considers both the...Read more

 Revenue - Geography
In addition to the United...Read more

 Other - Other
Our assessments are based on...Read more

 Other - Other
The purchase price is $350...Read more

 Other - Other
Phibro Animal Health Corporation is...Read more

 Revenue - Geography
We began operations at a...Read more

 Other - Other
In the ordinary course of...Read more

 Other - Other
While we initially had some...Read more



 
Financial Statements, Disclosures and Schedules
Inside this 10-K Annual Report





Document And Entity Information





Consolidated Balance Sheets





Consolidated Balance Sheets (Parentheticals)





Consolidated Statements Of Cash Flows





Consolidated Statements Of Changes In Stockholders' Equity





Consolidated Statements Of Changes In Stockholders' Equity (Parentheticals)





Consolidated Statements Of Comprehensive Income (Loss)





Consolidated Statements Of Operations





Balance Sheets-Additional Information





Balance Sheets-Additional Information (Tables)





Balance Sheets-Additional Information - Accounts Receivable, Net (Details)





Balance Sheets-Additional Information - Accrued Expenses And Other Current Liabilities (Details)





Balance Sheets-Additional Information - Accumulated Other Comprehensive Income (Loss) (Details)





Balance Sheets-Additional Information - Goodwill (Details)





Balance Sheets-Additional Information - Insurance Premium Financing (Details)





Balance Sheets-Additional Information - Intangibles, Net - Total (Details)





Balance Sheets-Additional Information - Intangibles, Net - Weighted-Average Useful Life (Details)





Balance Sheets-Additional Information - Inventories (Details)





Balance Sheets-Additional Information - Other Assets (Details)





Balance Sheets-Additional Information - Other Liabilities (Details)





Balance Sheets-Additional Information - Property, Plant And Equipment, Net - Additional Information (Details)





Balance Sheets-Additional Information - Property, Plant And Equipment, Net - Tabular Disclosure (Details)





Balance Sheets-Additional Information - Reserve For Credit Losses (Details)





Business Segments





Business Segments (Tables)





Business Segments - Adjusted Ebitda (Details)





Business Segments - Depreciation And Amortization (Details)





Business Segments - General Information (Details)





Business Segments - Identifiable Assets (Details)





Business Segments - Net Sales (Details)





Business Segments - Property, Plant And Equipment, Net (Details)





Business Segments - Reconciliation Of Income Before Income Taxes To Adjusted Ebitda (Details)





Commitments And Contingencies





Commitments And Contingencies - Employment And Severance Agreements (Details)





Commitments And Contingencies - Environmental (Details)





Commitments And Contingencies - Purchase Commitments (Details)





Common Stock, Preferred Stock And Dividends





Common Stock, Preferred Stock And Dividends (Tables)





Common Stock, Preferred Stock And Dividends - Common Stock (Details)





Common Stock, Preferred Stock And Dividends - Dividends (Details)





Common Stock, Preferred Stock And Dividends - Preferred Stock And Common Stock - Additional Information (Details)





Common Stock, Preferred Stock And Dividends - Preferred Stock And Common Stock - Tabular Disclosure (Details)





Debt





Debt (Tables)





Debt - Aggregate Maturities Of Long-Term Debt And Revolver (Details)





Debt - Classification (Details)





Debt - Derivatives (Details)





Debt - General Information (Details)





Debt - Interest Rates - Stated Rates (Details)





Debt - Interest Rates - Weighted Average Rates (Details)





Debt - Reconciliation (Details)





Derivatives





Derivatives (Tables)





Derivatives - Additional Information (Details)





Derivatives - Balance Sheet Location (Details)





Derivatives - Effects Of Derivatives (Details)





Derivatives - General Information (Details)





Derivatives - Notional Amounts (Details)





Description Of Business





Employee Benefit Plans





Employee Benefit Plans (Tables)





Employee Benefit Plans - 401(K) Retirement Savings Plan (Details)





Employee Benefit Plans - Accumulated Other Comprehensive Income (Loss) (Details)





Employee Benefit Plans - Actuarial Assumptions - Additional Information (Details)





Employee Benefit Plans - Actuarial Assumptions - Tabular Disclosure (Details)





Employee Benefit Plans - Annuity Purchase Agreement (Details)





Employee Benefit Plans - Asset Allocation (Details)





Employee Benefit Plans - Change In Fair Value Of Level 3 Assets (Details)





Employee Benefit Plans - Change In Plan Assets (Details)





Employee Benefit Plans - Change In Projected Benefit Obligation - Additional Information (Details)





Employee Benefit Plans - Change In Projected Benefit Obligation - Tabular Disclosure (Details)





Employee Benefit Plans - Estimated Future Benefit Payments (Details)





Employee Benefit Plans - Fair Value Assumptions (Details)





Employee Benefit Plans - Fair Values Of Plan Assets (Details)





Employee Benefit Plans - Funded Status (Details)





Employee Benefit Plans - General Information (Details)





Employee Benefit Plans - Net Periodic Pension Expense (Details)





Employee Benefit Plans - Other Employee Benefit Plans (Details)





Fair Value Measurements





Fair Value Measurements (Tables)





Fair Value Measurements - Assets Measured On Recurring Basis, Unobservable Inputs (Details)





Fair Value Measurements - Fair Value Of Assets (Details)





Fair Value Measurements - Liabilities Measured On Recurring Basis, Unobservable Inputs (Details)





Income Taxes





Income Taxes (Tables)





Income Taxes - Components Of Provision For Income Taxes (Details)





Income Taxes - Deferred Tax Assets And Liabilities (Details)





Income Taxes - Deferred Taxes Included In Consolidated Balance Sheets (Details)





Income Taxes - Global Intangible Low-Taxed Income (Details)





Income Taxes - Gross Unrecognized Tax Benefits Reconciliation (Details)





Income Taxes - Income (Loss) Before Income Taxes (Details)





Income Taxes - Liabilities Related To Uncertain Tax Positions (Details)





Income Taxes - Net Operating Loss Carry Forwards (Details)





Income Taxes - Reconciliation Of Federal Statutory Rate To Effective Tax Rate (Details)





Income Taxes - Repatriation (Details)





Income Taxes - Uncertain Tax Positions (Details)





Income Taxes - Valuation Allowance (Details)





Insider Trading Arrangements





Leases





Leases (Tables)





Leases - Assets And Liabilities (Details)





Leases - Composition Of Net Lease Cost (Details)





Leases - General Information (Details)





Leases - Gross Difference (Details)





Leases - Maturities Of Future Lease Liabilities (Details)





Leases - Other Supplemental Information (Details)





Pay Vs Performance Disclosure





Proposed Acquisition





Proposed Acquisition (Details)





Related Party Transactions





Related Party Transactions (Details)





Statements Of Operations-Additional Information





Statements Of Operations-Additional Information (Tables)





Statements Of Operations-Additional Information - Amortization Of Intangible Assets (Details)





Statements Of Operations-Additional Information - Capitalized Software (Details)





Statements Of Operations-Additional Information - Depreciation And Amortization (Details)





Statements Of Operations-Additional Information - General Information (Details)





Statements Of Operations-Additional Information - Interest Expense, Net (Details)





Statements Of Operations-Additional Information - Net Sales By Product Type (Details)





Statements Of Operations-Additional Information - Net Sales By Region (Details)





Statements Of Operations-Additional Information - Research And Development Expense (Details)





Statements Of Operations-Additional Information - Segments (Details)





Stock Incentive Plan





Stock Incentive Plan - Cost Not Yet Recognized (Details)





Stock Incentive Plan - General Information (Details)





Stock Incentive Plan - Restricted Stock Units (Details)





Stock Incentive Plan - Stock-Based Compensation Expense (Details)





Subsequent Event - 2024 Credit Agreement





Subsequent Event - 2024 Credit Agreement (Tables)





Subsequent Event - 2024 Credit Agreement - Derivatives (Details)





Subsequent Event - 2024 Credit Agreement - Financial Covenants (Details)





Subsequent Event - 2024 Credit Agreement - General Information (Details)





Subsequent Event - 2024 Credit Agreement - Interest Rates (Details)





Summary Of Significant Accounting Policies And New Accounting Standards





Summary Of Significant Accounting Policies And New Accounting Standards (Policies)





Summary Of Significant Accounting Policies And New Accounting Standards (Tables)





Summary Of Significant Accounting Policies And New Accounting Standards - Accounts Receivable And Allowance For Doubtful Accounts (Details)





Summary Of Significant Accounting Policies And New Accounting Standards - Derivative Financial Instruments (Details)





Summary Of Significant Accounting Policies And New Accounting Standards - Net Income Per Share And Weighted Average Shares (Details)





Summary Of Significant Accounting Policies And New Accounting Standards - New Accounting Standards (Details)





Summary Of Significant Accounting Policies And New Accounting Standards - Property, Plant And Equipment And Capitalized Software (Details)




 
Material Contracts, Statements, Certifications & more
Phibro Animal Health Corp provided additional information to their SEC Filing as exhibits





Exhibit 2.1: Plan Of Acquisition, Reorganization, Arrangement, Liquidation Or Succession





Exhibit 10.1: Material Contract





Exhibit 10.25: Material Contract





Exhibit 19.1: Report Composed To Security Holders





Exhibit 21.1: Subsidaries Of The Registrant





Exhibit 23.1: Consents Of Experts And Counsel





Exhibit 31.1: Rule 13A-14(A)/15D-14(A) Certification





Exhibit 31.2: Rule 13A-14(A)/15D-14(A) Certification





Exhibit 32.1: Section 1350 Certification





Exhibit 32.2: Section 1350 Certification





Exhibit 97.1: Ex-97.1






Ticker: PAHC CIK: 1069899
Form Type: 10-K Annual Report
Accession Number: 0001558370-24-012517
Submitted to the SEC: Wed Aug 28 2024 4:42:36 PM EST
Accepted by the SEC: Wed Aug 28 2024
Period:  Sunday, June 30, 2024
Industry: Pharmaceutical Preparations						
External Resources:
 Stock Quote
 Social Media
 SEC.gov

Bookmark the Permalink:
https://last10k.com/sec-filings/pahc/0001558370-24-012517.htm








About 
											Contact 
											Help 
											API 
											Privacy 
											Terms 
									


© 2012 - 2024 Last10K.com All Rights Reserved









×
You're Signed Out
Sign in for the full experience


Sign in
Join Now








Intrinsic Value Calculator








Screenshot of intrinsic value for AT&T (2019)




Last10K.com Member Feature

Our Intrinsic Value calculator estimates what an entire company is worth using up to 10 years of financial ratios to determine if a stock is overvalued or not
Continue












Never Miss A New SEC Filing Again








Screenshot taken from Gmail for a new 10-K Annual Report




Last10K.com Member Feature

Receive an e-mail as soon as a company files an Annual Report, Quarterly Report or has new 8-K corporate news
Continue












We Highlighted This SEC Filing For You








Screenshot taken from Wynn's 2018 10-K Annual Report




Last10K.com Member Feature

Read positive and negative remarks made by management in their entirety without having to find them in a 10-K/Q
Continue












Widen Your SEC Filing Reading Experience








Screenshot taken from Adobe Inc.'s 10-Q Quarterly Report




Last10K.com Member Feature

Remove data columns and navigations in order to see much more filing content and tables in one view
Continue












Uncover Actionable Information Inside SEC Filings








Screenshot taken from Lumber Liquidators 10-K Annual Report




Last10K.com Member Feature

Read both hidden opportunities and early signs of potential problems without having to find them in a 10-K/Q
Continue












Adobe PDF, Microsoft Word, Excel and CSV Downloads








Screenshots of actual 10-K and 10-Q SEC Filings in PDF, Word and Excel formats




Last10K.com Member Feature

Export Annual and Quarterly Reports to Adobe Acrobat (PDF), Microsoft Word (DOCX), Excel (XLSX) and Comma-Delimited (CSV) files for offline viewing, annotations and analysis
Continue












Adobe PDF, Microsoft Word, Excel and CSV Downloads








Screenshots of actual 10-K and 10-Q SEC Filings in PDF, Word and Excel formats




Last10K.com Member Feature

Export Annual and Quarterly Reports to Adobe Acrobat (PDF), Microsoft Word (DOCX), Excel (XLSX) and Comma-Delimited (CSV) files for offline viewing, annotations and analysis
Continue












Financial Stability Report








Screenshot of financial stability report for Coco-Cola (2019)




Last10K.com Member Feature

Our Financial Stability reports uses up to 10 years of financial ratios to determine the health of a company's EPS, Dividends, Book Value, Return on Equity, Current Ratio and Debt-to-Equity
Continue












Get a Better Picture of a Company's Performance








Available Financial Ratios




Last10K.com Member Feature

See how over 70 Growth, Profitability and Financial Ratios perform over 10 Years
Continue












See when company executives buy or sell their own stock








Screenshot taken from Euronet (EEFT)




Last10K.com Member Feature

Use our calculated cost dollar values to discover when and how much registered owners BUY, SELL or excercise their company stock OPTIONS aggregated from Form 4 Insider Transactions SEC Filings
Continue












See how institutional managers trade a stock








Screenshot taken from General Motors (GM)




Last10K.com Member Feature

View which hedge funds, pension / retirement funds, endowments, banks and insurance companies have increased or decreased their positions in a particular stock. Includes Ownership Percent, Buy versus Sell comparison, Put-Call ratio and more
Continue












FREE Financial Statements








Screenshot of actual balance sheet from company 10-K Annual Report




Last10K.com Member Feature

Get one-click access to balance sheets, income, operations and cash flow statements without having to find them in Annual and Quarterly Reports
Continue for FREE












SEC Filing Exhibit
 PDF Download



Loading SEC Filing Exhibit...








SEC Filing Financial Summary
 PDF Download
 Excel Download



Loading SEC Filing Financial Summary...

